Featured Intelligence

Insurers have begun exploring epigenetic testing, the same kind of biological age technology increasingly discussed in longevity medicine, as a tool for evaluating life insurance applicants. At least one major life insurer has already partnered with a genomics company to

Gum disease has long been treated as a localized dental problem, something to manage with better brushing and regular cleanings, separate from the rest of a person's health. That framing is looking increasingly incomplete. Researchers have identified a

A few months in orbit produces changes in healthy, carefully screened astronauts that echo several recognized hallmarks of aging, shifts in stem cell function, gene expression, immune activity, and the gut microbiome, all compressed into a fraction of the time

GLP-1 drugs have dominated the conversation about obesity treatment for the past several years, but a large real-world comparison spanning more than thirty studies and over four hundred thousand patients found something worth sitting with: metabolic and bariatric

Eight children born in the United Kingdom using a technique that combines genetic material from three people are now the subject of the first published, peer-reviewed results on how the approach actually performs in practice. The technique, mitochondrial donation,

A striking finding in aging mice, that exposure to young blood could improve muscle repair, brain function, and even extend lifespan, has quietly powered an entire corner of the longevity industry for over a decade. Clinics offer young donor plasma

Since long COVID first emerged as a recognized condition, it has been diagnosed almost entirely by exclusion, a doctor ruling out other explanations for a patient's fatigue, breathlessness, or exercise intolerance rather than confirming the condition with any

A stem cell therapy for knee osteoarthritis just secured a large new round of funding to push it into a pivotal Phase III trial, the last major step before a treatment can seek approval. The therapy uses mesenchymal stem cells

A small device implanted on the vagus nerve, rather than a drug, just cleared its most rigorous test yet as a treatment for rheumatoid arthritis. In a pivotal, sham-controlled trial of 242 patients who had not responded well to